tiprankstipranks
Advertisement
Advertisement

Health In Tech advances AI platform and leadership expansion

Story Highlights
  • Health In Tech posted strong 2025 growth, with revenue up 71% and profitability improving despite a small fourth-quarter loss.
  • The company is expanding its AI-driven InsurTech platform, leadership and product suite to gain share in self-funded health and U.S. claims markets.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Health In Tech advances AI platform and leadership expansion

Claim 55% Off TipRanks

The latest update is out from Health In Tech, Inc. Class A ( (HIT) ).

Health In Tech reported strong growth for the quarter and year ended December 31, 2025, with full-year revenue rising 71% to $33.3 million and adjusted EBITDA up 81% to $4.1 million, while net income increased to $1.3 million despite a fourth-quarter net loss. The company expanded its base of billed enrolled employees and distribution partners, maintained a cash balance of $7.7 million, and in early 2026 bolstered its AI-driven platform and leadership team, introduced more than 100 pre-configured stop-loss plans, and used events such as its inaugural hitDavos InsurTech Summit to sharpen its positioning in the U.S. claims administration market and support its strategy of scaling a fully integrated marketplace model.

Health In Tech’s rapid deployment cycle for new capabilities, typically within one to two quarters versus the traditional industry’s one to two years, underpins its competitive edge as it extends services beyond underwriting into areas like claims administration and cost-containment solutions. Recent moves, including partnerships with AWS-focused Ciklum, the appointments of a new CTO and Chief Growth Officer, and ongoing testing of new stabilization and data-driven offerings in the first half of 2026, signal an intensifying push to drive durable growth, improve operating leverage and shorten sales cycles for stakeholders across its distribution network.

The most recent analyst rating on (HIT) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Health In Tech, Inc. Class A stock, see the HIT Stock Forecast page.

Spark’s Take on HIT Stock

According to Spark, TipRanks’ AI Analyst, HIT is a Neutral.

The score is supported primarily by strong fundamental performance and a positive earnings outlook, but is held back by weak technical trend signals and a high P/E valuation with no dividend yield support.

To see Spark’s full report on HIT stock, click here.

More about Health In Tech, Inc. Class A

Health In Tech, Inc. is a Nasdaq-listed, AI-enabled InsurTech platform focused on streamlining processes in the health insurance industry through vertical integration, automation and a digital marketplace. The company targets the self-funded health insurance segment, serving carriers, brokers, third-party administrators and agencies with tools to simplify underwriting, sales and service workflows.

Average Trading Volume: 355,177

Technical Sentiment Signal: Sell

Current Market Cap: $103.6M

See more insights into HIT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1